TAG ARCHIVES FOR guidance

8
Dec2012

by Julie Fine, BS, legal specialist, Legal Division, Worldwide Research and Development, Pfizer Inc. (Please note: The views presented here are my own and do not reflect the positions or policies of Pfizer Inc.)

On Thursday, I attended Challenges in Securing Coverage for Research-Related Injury, a session which was presented by my colleague, Marc D. Francis, JD, Pfizer Legal, and Karen E. Moe, PhD, University of Washington. Marc began by [...] Read more

9
Apr2012

The 2012 Institutional Animal Care and Use Committee (IACUC) Conference hosted several forums that provided insight into complex issues in the field of animal care and use.

One such topic that was discussed at the conference was a webinar, Use of Non-Pharmaceutical-Grade Chemicals and Other Substances in Research with Animals, [...] Read more

29
Feb2012

by Andrew N Rowan, PhD, Chief Scientific Officer of The Humane Society of the United States, PRIM&R Board Member, 1985-2010

The use of chimpanzees in invasive experiments has been a controversial issue for decades with proponents arguing that chimpanzee use is necessary to advance human health and opponents arguing that the practice is both unnecessary and unethical. Recent developments could lead to a possible resolution of this issue.

A National Academies’ Institute of Medicine (IOM) committee spent approximately eight months last year examining the necessity of using chimpanzees in biomedical and behavioral research. The Read more

20
Dec2011

PRIM&R is pleased to bring you a post from Dawnett Watkins, a member of the PRIM&R Blog Squad at the 2011 Advancing Ethical Research Conference. The PRIM&R Blog Squad is composed of PRIM&R members who are devoted to blogging prior to, live from, and after our conferences.

How do the current guidelines define who is a prisoner?  Read more

Page 2 of 3123